Lakefront Biotherapeutics NV (LKFT34.SA) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-4.65
-2.7
-0.75
1.2

Details

Expected EPS
-4.649700424309984
Actual EPS
1.19799853152
Surprise EPS
5.85
Surprise Percent
+125.77%

Description

Lakefront Biotherapeutics NV (LKFT34.SA) has reported earnings of 1.19799853152 per share for Q2 2026.

0 Comments

Share your thoughts